Health & Nutrition

bg
Florida law models what genetic disease testing could be

Florida law models what genetic disease testing could be

A Florida state legislator sponsored the nation's first state-backed genetic screening...

bg
Nuts, Sperm, and Sex: The Surprising Connection

Nuts, Sperm, and Sex: The Surprising Connection

Walnuts, almonds, and hazelnuts are put to the test for erectile and sexual function,...

bg
Which Foods Help a Leaky Gut?

Which Foods Help a Leaky Gut?

What is the recommended diet for treating leaky gut? Which foods and food components...

bg
Hims & Hers pulls copycat weight-loss pill after threats of legal action

Hims & Hers pulls copycat weight-loss pill after threats...

Hims & Hers on Saturday announced it would stop offering its copycat of the...

bg
Healthy Returns: Pfizer execs chart out obesity strategy after encouraging drug data

Healthy Returns: Pfizer execs chart out obesity strategy...

Pfizer made one thing clear this week: It's officially back in the obesity race. 

bg
White House launches direct-to-consumer drug site TrumpRx. Here's what to know

White House launches direct-to-consumer drug site TrumpRx....

It's still unclear if all patients, particularly those with insurance coverage,...

bg
Eli Lilly's GLP-1 growth is only getting started as Novo Nordisk braces for a decline in 2026

Eli Lilly's GLP-1 growth is only getting started as Novo...

The split in outlook underscores Lilly's strong position in the obesity market,...

bg
Eli Lilly blows past quarterly estimates, posts strong outlook as Zepbound and Mounjaro sales soar

Eli Lilly blows past quarterly estimates, posts strong...

Eli Lilly's full-year guidance comes in stark contrast to the outlook of Novo Nordisk,...

bg
Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial

Pfizer says obesity injection shows promise as monthly...

The data on Pfizer's GLP-1 offer early evidence that the injection can be administered...

bg
Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook

Pfizer beats quarterly estimates despite Covid product...

The pharmaceutical giant reaffirmed the modest 2026 outlook that rattled investors...